Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trial.

MLA

Hirata, Kenro, et al. “Definitive Chemoradiotherapy with Paclitaxel for Locally Advanced Esophageal Squamous Cell Carcinoma in Older Patients (PARADISE-1): A Phase I Trial.” BMC Cancer, vol. 24, no. 1, July 2024, p. 873. EBSCOhost, https://doi.org/10.1186/s12885-024-12653-4.

APA

Hirata, K., Yoshida, K., Katada, C., Watanabe, A., Tsushima, T., Yamaguchi, T., Yamamoto, S., Ishikawa, H., Sato, Y., Imamura, C. K., Tanigawara, Y., Ito, Y., Kato, K., Kitagawa, Y., & Hamamoto, Y. (2024). Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trial. BMC Cancer, 24(1), 873. https://doi.org/10.1186/s12885-024-12653-4

Chicago

Hirata, Kenro, Kayo Yoshida, Chikatoshi Katada, Akinori Watanabe, Takahiro Tsushima, Toshifumi Yamaguchi, Sachiko Yamamoto, et al. 2024. “Definitive Chemoradiotherapy with Paclitaxel for Locally Advanced Esophageal Squamous Cell Carcinoma in Older Patients (PARADISE-1): A Phase I Trial.” BMC Cancer 24 (1): 873. doi:10.1186/s12885-024-12653-4.